Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
暂无分享,去创建一个
A. Valizadeh | Samad Mussa Farkhani | S. Mohammadi | Hadi Karami | F. Badrzadeh | Alireza Valizadeh | Hadi Karami | Samane Mohammadi | Fariba Badrzadeh | Samaneh Mohammadi
[1] H. Okada,et al. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery. , 2010, International journal of pharmaceutics.
[2] Sabine Boeckle,et al. Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[3] A. Lawrie,et al. Peptide‐mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes , 2012, Journal of peptide science : an official publication of the European Peptide Society.
[4] W. Banks,et al. Transport across the Blood-Brain Barrier of Pluronic Leptin , 2010, Journal of Pharmacology and Experimental Therapeutics.
[5] Munia Ganguli,et al. Structural rearrangements and chemical modifications in known cell penetrating peptide strongly enhance DNA delivery efficiency. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[6] Ű. Langel,et al. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.
[7] C. Montero-Menei,et al. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. , 2011, Biomaterials.
[8] M. Rhee,et al. Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide* , 2006, Journal of Biological Chemistry.
[9] Henrik J Johansson,et al. Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] B. Nordén,et al. Stimulated endocytosis in penetratin uptake: effect of arginine and lysine. , 2008, Biochemical and biophysical research communications.
[11] Igor L. Medintz,et al. Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. , 2006, Bioconjugate chemistry.
[12] S. Futaki,et al. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. , 2008, International journal of pharmaceutics.
[13] H. Okada,et al. Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing. , 2010, International journal of pharmaceutics.
[14] Yongzhuo Huang,et al. TAT-modified nanosilver for combating multidrug-resistant cancer. , 2012, Biomaterials.
[15] Vladimir P Torchilin,et al. Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. , 2013, Cancer letters.
[16] Yue-Wern Huang,et al. Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. , 2011, Biomaterials.
[17] V. Torchilin,et al. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[18] M. De Waard,et al. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. , 2009, Cancer letters.
[19] S. M. Robinson,et al. Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. , 2005, Bioconjugate chemistry.
[20] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[21] C. Rousselle,et al. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. , 2001, The Journal of pharmacology and experimental therapeutics.
[22] Beatriz Pelaz,et al. The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. , 2010, Biomaterials.
[23] Mark A. Kay,et al. Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.
[24] G. Rádis-Baptista,et al. Insights into the Uptake Mechanism of NrTP, A Cell‐Penetrating Peptide Preferentially Targeting the Nucleolus of Tumour Cells , 2012, Chemical biology & drug design.
[25] J. Conde,et al. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles , 2012, Journal of Nanoparticle Research.
[26] Tae Gwan Park,et al. PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[27] Sonia Aroui,et al. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. , 2010, Biochemical and biophysical research communications.
[28] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[29] Shawn J. Tan,et al. Surface coating directed cellular delivery of TAT-functionalized quantum dots. , 2009, Bioconjugate chemistry.
[30] Azam Bolhassani,et al. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. , 2011, Biochimica et biophysica acta.
[31] Han-Jung Lee,et al. Arginine-rich cell-penetrating peptides deliver gene into living human cells. , 2012, Gene.
[32] Keliang Liu,et al. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate). , 2012, International journal of pharmaceutics.
[33] Y. Maitani,et al. Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG. , 2009, International journal of pharmaceutics.
[34] O. Lequin,et al. Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency. , 2006, Biochemistry.
[35] Roger Y Tsien,et al. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[36] Erwin G. Van Meir,et al. Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.
[37] Rongqin Huang,et al. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. , 2010, Biomaterials.
[38] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Scherrmann,et al. CNS Delivery Via Adsorptive Transcytosis , 2008, The AAPS Journal.
[40] John Archdeacon,et al. A non-covalent peptide-based carrier for in vivo delivery of DNA mimics , 2007, Nucleic acids research.
[41] D. Luo,et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.
[42] Jesus M de la Fuente,et al. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. , 2005, Bioconjugate chemistry.
[43] C. Berkland,et al. Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery. , 2011, Journal of pharmaceutical sciences.
[44] Quanyin Hu,et al. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. , 2013, Biomaterials.
[45] Cornelis J. Weijer,et al. Visualizing Signals Moving in Cells , 2003, Science.
[46] A. Kastin. Handbook of biologically active peptides , 2006 .
[47] T. Tanabe,et al. The conjugation of diphtheria toxin T domain to poly(ethylenimine) based vectors for enhanced endosomal escape during gene transfection. , 2009, Biomaterials.
[48] M. Pooga,et al. Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] E. Jabbari,et al. Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[50] Qi Shen,et al. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[51] D. Ly,et al. Multicolor Coding of Cells with Cationic Peptide Coated Quantum Dots , 2004 .
[52] Fan-Ching Chien,et al. Targeted nuclear delivery using peptide-coated quantum dots. , 2011, Bioconjugate chemistry.
[53] M. Morris,et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.
[54] Maurice Green,et al. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein , 1988, Cell.
[55] Qiang Zhang,et al. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. , 2012, Biomaterials.
[56] M. Mano,et al. Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems , 2010, Pharmaceuticals.
[57] Vladimir P Torchilin,et al. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. , 2009, International journal of pharmaceutics.
[58] Ülo Langel,et al. Handbook of cell-penetrating peptides , 2006 .
[59] Soodabeh Davaran,et al. Quantum dots: synthesis, bioapplications, and toxicity , 2012, Nanoscale Research Letters.
[60] É. Kiss,et al. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates. , 2012, European journal of medicinal chemistry.
[61] R. Brasseur,et al. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] S. Futaki,et al. Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.
[63] Jianping Xie,et al. The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes. , 2013, Nanoscale.
[64] Daniele Gerion,et al. Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and , 2004 .
[65] C. Nunes,et al. S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane-mimetic lipid systems and cell membranes: implications for cell internalization. , 2012, Biochimica et biophysica acta.
[66] J. Rich,et al. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] T. Fujita,et al. New short interfering RNA-based therapies for glomerulonephritis , 2011, Nature Reviews Nephrology.
[68] I. Khalil,et al. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[69] Y. Zhen,et al. A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[70] Donald W. Miller,et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.
[71] Xinguo Jiang,et al. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. , 2012, International journal of pharmaceutics.
[72] Juan B. Blanco-Canosa,et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.
[73] F. Ren,et al. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively. , 2013, Biochimie.
[74] R. Schwendener,et al. Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes , 2004, Cellular and Molecular Life Sciences CMLS.
[75] S. Futaki,et al. Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. , 2006, Biochimica et biophysica acta.
[76] I. Mäger,et al. PepFect14 peptide vector for efficient gene delivery in cell cultures. , 2013, Molecular pharmaceutics.
[77] J. Conde,et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. , 2012, ACS nano.
[78] Jeremy C Simpson,et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[79] T. Torgerson,et al. Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.
[80] Cheol Moon,et al. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[81] Lin Zhu,et al. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.
[82] J. Xue,et al. Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. , 2010, Biomaterials.
[83] A. F. Saleh,et al. Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[84] Jeffrey D. Esko,et al. Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.
[85] Yue-Wern Huang,et al. A gene delivery system for human cells mediated by both a cell-penetrating peptide and a piggyBac transposase. , 2011, Biomaterials.
[86] J. Gariépy,et al. The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP-protein cargos to the cytosol of eukaryotic cells. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[87] B. Wiesner,et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.
[88] Rangeetha J Naik,et al. Different roles of cell surface and exogenous glycosaminoglycans in controlling gene delivery by arginine-rich peptides with varied distribution of arginines. , 2013, Biochimica et biophysica acta.
[89] S. Futaki,et al. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[90] Kevin G. Rice,et al. Peptide-guided gene delivery , 2007, The AAPS Journal.
[91] J. Seelig,et al. Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds. , 2008, Biophysical journal.
[92] Min Liu,et al. Paramagnetic particles carried by cell-penetrating peptide tracking of bone marrow mesenchymal stem cells, a research in vitro. , 2006, Biochemical and biophysical research communications.
[93] T. Fujiwara,et al. Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis. , 2010, Biochemical and biophysical research communications.
[94] W. Pardridge,et al. Blood-brain barrier delivery. , 2007, Drug discovery today.
[95] C. Berkland,et al. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing. , 2012, International journal of pharmaceutics.
[96] Qianjun He,et al. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. , 2013, Biomaterials.
[97] J. Esko,et al. Heparan sulfate proteoglycans. , 2011, Cold Spring Harbor perspectives in biology.
[98] Ű. Langel,et al. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery. , 2013, ACS nano.
[99] R. Nitschke,et al. Quantum dots versus organic dyes as fluorescent labels , 2008, Nature Methods.
[100] Haiyang Tang,et al. Applications of mesenchymal stem cells labeled with Tat peptide conjugated quantum dots to cell tracking in mouse body. , 2008, Bioconjugate chemistry.
[101] Gang Bao,et al. Tat Peptide Is Capable of Importing Large Nanoparticles Across Nuclear Membrane in Digitonin Permeabilized Cells , 2009, Annals of Biomedical Engineering.
[102] Tianyue Jiang,et al. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. , 2012, Biomaterials.
[103] Ting-Yi Wang,et al. Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges , 2012, Pharmaceuticals.
[104] Igor L. Medintz,et al. Delivering quantum dots into cells: strategies, progress and remaining issues , 2009, Analytical and bioanalytical chemistry.
[105] K. Lim,et al. Intracellular organelle-targeted non-viral gene delivery systems. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[106] Shana O Kelley,et al. Recent advances in the use of cell-penetrating peptides for medical and biological applications. , 2009, Advanced drug delivery reviews.
[107] A. Marcus,et al. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. , 2007, Journal of the American Chemical Society.
[108] T. Maekawa,et al. Intracellular trafficking of superparamagnetic iron oxide nanoparticles conjugated with TAT peptide: 3-dimensional electron tomography analysis. , 2012, Biochemical and biophysical research communications.
[109] P. Wender,et al. The design of guanidinium-rich transporters and their internalization mechanisms. , 2008, Advanced drug delivery reviews.
[110] Steven F Dowdy,et al. Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[111] Brenda Russell,et al. Delivery and visualization of proteins conjugated to quantum dots in cardiac myocytes. , 2008, Journal of molecular and cellular cardiology.
[112] T. Ohtsuki,et al. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. , 2009, Advanced drug delivery reviews.
[113] L. Ren,et al. Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[114] Kairong Wang,et al. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. , 2011, Bioconjugate chemistry.
[115] N. Kaji,et al. Quantum dots labeling using octa-arginine peptides for imaging of adipose tissue-derived stem cells. , 2010, Biomaterials.
[116] P. Johnston,et al. Molecular mechanisms of drug resistance , 2005, The Journal of pathology.
[117] X. Qi,et al. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells. , 2011, International journal of pharmaceutics.
[118] Leroy Cronin,et al. Quantum Dots Protected with Tiopronin: A New Fluorescence System for Cell‐Biology Studies , 2005, Chembiochem : a European journal of chemical biology.
[119] M. De Waard,et al. Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase. , 2010, Biochemical and biophysical research communications.
[120] Jicun Ren,et al. Characterization of quantum dot bioconjugates by capillary electrophoresis with laser-induced fluorescent detection. , 2006, Journal of chromatography. A.
[121] J. Temsamani,et al. The use of cell-penetrating peptides for drug delivery. , 2004, Drug discovery today.
[122] K. Makino,et al. Induction of autophagic cell death of glioma-initiating cells by cell-penetrating D-isomer peptides consisting of Pas and the p53 C-terminus. , 2012, Biomaterials.
[123] W. Pardridge,et al. Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[124] F. Milletti,et al. Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.
[125] Quanyin Hu,et al. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. , 2013, Biomaterials.
[126] Vladimir P Torchilin,et al. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[127] Felix Kratz,et al. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. , 2012, International journal of pharmaceutics.
[128] E. Clementi,et al. Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events , 2006, Journal of Cell Science.
[129] Gert Storm,et al. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[130] K. Parang,et al. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs. , 2013, Molecular pharmaceutics.
[131] Steven F Dowdy,et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.
[132] Igor L. Medintz,et al. Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides. , 2008, Bioconjugate chemistry.
[133] T. Rana,et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.
[134] A. Kastin,et al. Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. , 1998, Journal of cell science.
[135] V. Torchilin,et al. Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. , 2013, Cancer letters.
[136] Lin‐Yue Lanry Yung,et al. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. , 2013, International journal of pharmaceutics.
[137] S. Futaki,et al. Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[138] Quanyin Hu,et al. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. , 2013, Biomaterials.
[139] D. Burgess,et al. DNA-based therapeutics and DNA delivery systems: A comprehensive review , 2005, The AAPS Journal.
[140] A. Kabanov,et al. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. , 2001, The Journal of pharmacology and experimental therapeutics.
[141] L. Kőhidai,et al. Daunomycin-polypeptide conjugates with antitumor activity. , 2010, Biochimica et biophysica acta.
[142] P. Iversen,et al. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[143] B. Nordén,et al. Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans. , 2012, Biochimica et biophysica acta.
[144] A. Magyar,et al. New daunomycin–oligoarginine conjugates: Synthesis, characterization, and effect on human leukemia and human hepatoma cells , 2009, Biopolymers.
[145] M. Giacca,et al. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. , 2005, The Biochemical journal.
[146] Ü. Langel,et al. A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[147] B. Lagerholm. Peptide-mediated intracellular delivery of quantum dots. , 2007, Methods in molecular biology.
[148] Astrid Gräslund,et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. , 2012, Accounts of chemical research.
[149] Jun F. Liang,et al. Constructing bioactive peptides with pH-dependent activities , 2009, Peptides.
[150] Tuan Vo-Dinh,et al. TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. , 2012, Journal of the American Chemical Society.
[151] Astrid Gräslund,et al. Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.
[152] Ű. Langel,et al. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[153] X. Qi,et al. Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage , 2012, International journal of nanomedicine.
[154] S. Kelley,et al. Cell-penetrating peptides as delivery vehicles for biology and medicine. , 2008, Organic & biomolecular chemistry.
[155] Vladimir P Torchilin,et al. Cell-penetrating peptides: breaking through to the other side. , 2012, Trends in molecular medicine.
[156] W. Jiskoot,et al. OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. , 2004, Biochimica et biophysica acta.
[157] A. Herrmann,et al. Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[158] W. Lee,et al. Cationic oligopeptide‐mediated delivery of dsRNA for post‐transcriptional gene silencing in plant cells , 2004, FEBS letters.
[159] F. Beltram,et al. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[160] G. Tang,et al. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. , 2011, Biomaterials.
[161] J. Spatz,et al. Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors. , 2010, ACS nano.
[162] Yue-Wern Huang,et al. Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence , 2012, Peptides.
[163] S. Futaki,et al. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.
[164] Z. Bozsó,et al. Cell-penetrating peptide exploited syndecans. , 2010, Biochimica et biophysica acta.
[165] Yue-Wern Huang,et al. Nona-Arginine Facilitates Delivery of Quantum Dots into Cells via Multiple Pathways , 2010, Journal of biomedicine & biotechnology.
[166] J. M. Kumar,et al. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. , 2012, Biomaterials.
[167] P. N. Wang,et al. Enhancement of Intracellular Delivery of CdTe Quantum Dots (QDs) to Living Cells by Tat Conjugation , 2007, Journal of Fluorescence.
[168] B. Davidson,et al. Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.
[169] P. Lundin,et al. A Peptide-based Vector for Efficient Gene Transfer In Vitro and In Vivo. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[170] T. Bártfai,et al. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. , 2001, Experimental cell research.
[171] K. Parang,et al. Cyclic peptide-capped gold nanoparticles as drug delivery systems. , 2013, Molecular pharmaceutics.
[172] P. Nielsen,et al. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. , 2005, Chemistry & biology.
[173] H. Cui,et al. Self-assembled Tat nanofibers as effective drug carrier and transporter. , 2013, ACS nano.
[174] A. Kabanov,et al. New technologies for drug delivery across the blood brain barrier. , 2004, Current pharmaceutical design.
[175] Jean-Pierre Benoit,et al. Active targeting of brain tumors using nanocarriers. , 2007, Biomaterials.
[176] Yue-Wern Huang,et al. Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. , 2010, Journal of nanoscience and nanotechnology.
[177] J. Gariépy,et al. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. , 2007, Biochemical Society transactions.
[178] C. Contag,et al. Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters , 2008, Proceedings of the National Academy of Sciences.
[179] Min Gong,et al. Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin. , 2012, International journal of pharmaceutics.
[180] G. Mariani,et al. Multidrug resistance in cancer: its mechanism and its modulation. , 2007, Drug news & perspectives.
[181] Erik J. Sontheimer,et al. Assembly and function of RNA silencing complexes , 2005, Nature Reviews Molecular Cell Biology.
[182] Tae Gwan Park,et al. Thermally triggered cellular uptake of quantum dots immobilized with poly(N-isopropylacrylamide) and cell penetrating peptide. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[183] Victoria J Allan,et al. Light Microscopy Techniques for Live Cell Imaging , 2003, Science.
[184] Ke-Xin Zhang,et al. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. , 2008, Bioconjugate chemistry.
[185] Young-Suk Choi,et al. Cell‐penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy , 2011, International journal of cancer.
[186] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[187] W. Banks,et al. Principles of strategic drug delivery to the brain (SDDB): Development of anorectic and orexigenic analogs of leptin , 2011, Physiology & Behavior.
[188] Mathias Brust,et al. Uptake and intracellular fate of surface-modified gold nanoparticles. , 2008, ACS nano.
[189] Álvaro Somoza,et al. Synthesis and surface modification of uniform MFe2O4 (M = Fe, Mn, and Co) nanoparticles with tunable sizes and functionalities , 2012, Journal of Nanoparticle Research.
[190] R. Gabathuler,et al. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.
[191] M. Ishino,et al. Mutational analysis of HIV-1 Tat minimal domain peptides: Identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression , 1989, Cell.
[192] Amit Modgil,et al. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[193] M. Morris,et al. Cell‐penetrating peptides: from molecular mechanisms to therapeutics , 2008, Biology of the cell.
[194] A. Prochiantz,et al. Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.
[195] S. Prakash,et al. Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. , 2013, Biomaterials.
[196] K. Lee,et al. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery. , 2013, Carbohydrate polymers.
[197] Glenn Walter,et al. Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.
[198] C. Berkland,et al. Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. , 2011, Molecular pharmaceutics.
[199] I. Neundorf,et al. Knockdown of a G protein-coupled receptor through efficient peptide-mediated siRNA delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[200] Shiroh Futaki,et al. High Density of Octaarginine Stimulates Macropinocytosis Leading to Efficient Intracellular Trafficking for Gene Expression* , 2006, Journal of Biological Chemistry.
[201] Yu Chen,et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.